Ozempic, a medication used to treat type 2 diabetes and promote weight loss, is experiencing a surge in popularity within the pharmaceutical market. This is due to its effectiveness in managing blood sugar levels and its potential to impact other sectors within the US retail market.

Companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart are mentioned in this report as being affected by the increased use of GLP-1 drugs. These drugs have implications for various sectors within the retail industry, including grocery and apparel.

This report is exclusive to subscribers only and provides valuable insights into the effects of widespread GLP-1 drug use on the retail industry. Subscribers can log in to access the document and gain a deeper understanding of this topic. If you are not a subscriber, you can learn more about subscriptions and access to relevant research.